0.68%
-0.67%
4.20%
7.97%
34.23%
20.16%
-14.37%
AI Spotlight on VBSN
Company Description
IVF Hartmann Holding AG provides medical consumer goods in Switzerland and internationally.The company offers surgical disposable instruments, blankets, clothing and gloves, disinfection and hygiene products, wound management and hydrotherapy services, incontinence management, and first aid products, as well as various courses.It serves private doctors; outpatient medicine and care; hospitals and clinics; pharmacies and drugstores; nursing homes; and medical and food retailers, as well as industrial customers.
The company was formerly known as IVF and changed its name to IVF Hartmann Holding AG in 1993.The company was founded in 1874 and is headquartered in Neuhausen am Rheinfall, Switzerland.
Market Data
| Last Price | 149 |
| Change Percentage | 0.68% |
| Open | 149 |
| Previous Close | 148 |
| Market Cap ( Millions) | 355 |
| Volume | 142 |
| Year High | 153 |
| Year Low | 108 |
| M A 50 | 150.24 |
| M A 200 | 139.41 |
Financial Ratios
| FCF Yield | 8.28% |
| Dividend Yield | 2.15% |
| ROE | 12.06% |
| Debt / Equity | 3.73% |
| Net Debt / EBIDTA | -250.12% |
| Price To Book | 2.51 |
| Price Earnings Ratio | 20.12 |
| Price To FCF | 12.08 |
| Price To sales | 2.32 |
| EV / EBITDA | 10.8 |
News
Business Breakdown
Expected Mid-Term Growth
Segment n°1 -> Infection Management
Expected Growth : 4.8 %
What the company do ?
Infection Management from IVF Hartmann Holding AG refers to the prevention and control of hospital-acquired infections, ensuring a safe environment for patients and healthcare workers.
Why we expect these perspectives ?
Increasing awareness about hospital-acquired infections, growing demand for infection prevention and control measures, and advancements in medical technology are driving the growth of the Infection Management segment.
Segment n°2 -> Wound Care
Expected Growth : 4.8 %
What the company do ?
Wound Care from IVF Hartmann Holding AG provides innovative wound management solutions, offering a range of products for acute and chronic wounds, including dressings, bandages, and compression therapy.
Why we expect these perspectives ?
Increasing prevalence of chronic wounds, growing geriatric population, and advancements in wound care technologies drive the demand for innovative wound management solutions, such as those offered by IVF Hartmann Holding AG.
Segment n°3 -> Incontinence Management
Expected Growth : 4.8 %
What the company do ?
Incontinence Management from IVF Hartmann Holding AG provides innovative solutions for managing incontinence, offering a range of products and services to improve quality of life.
Why we expect these perspectives ?
Growing demand for incontinence management solutions, increasing awareness about incontinence, and innovative products from IVF Hartmann Holding AG drive market growth.
Segment n°4 -> Other
Expected Growth : 4.5 %
What the company do ?
The 'Other' segment from IVF Hartmann Holding AG includes revenue from non-core businesses, such as engineering services and trading activities.
Why we expect these perspectives ?
The 'Other' segment's growth is driven by increasing demand for engineering services and trading activities, fueled by industrial automation and digitalization trends, as well as the company's strategic expansion into new markets.
Ivf Hartmann Holding Ag Products
| Product Range | What is it ? |
|---|---|
| Medical Devices | IVF Hartmann Holding AG offers a range of medical devices for hospitals, clinics, and medical practices, including surgical instruments, implantable devices, and diagnostic equipment. |
| Orthopedic Implants | The company provides a variety of orthopedic implants, including joint replacements, osteosynthesis systems, and spinal implants. |
| Surgical Instruments | IVF Hartmann Holding AG offers a comprehensive range of surgical instruments, including forceps, scissors, and retractors. |
| Diagnostic Equipment | The company provides diagnostic equipment, including ultrasound machines, ECG devices, and patient monitoring systems. |
| Wound Care Products | IVF Hartmann Holding AG offers a range of wound care products, including dressings, bandages, and surgical sutures. |
| Infection Prevention Products | The company provides infection prevention products, including disinfectants, sterilization equipment, and personal protective equipment. |
IVF Hartmann Holding AG's Porter Forces
Threat Of Substitutes
The threat of substitutes for IVF Hartmann Holding AG is moderate, as there are alternative products and services available in the market, but they are not highly attractive to customers.
Bargaining Power Of Customers
The bargaining power of customers for IVF Hartmann Holding AG is low, as customers have limited options and the company has a strong brand presence.
Bargaining Power Of Suppliers
The bargaining power of suppliers for IVF Hartmann Holding AG is moderate, as suppliers have some negotiating power, but the company has a diversified supply chain.
Threat Of New Entrants
The threat of new entrants for IVF Hartmann Holding AG is high, as the market is attractive and there are low barriers to entry.
Intensity Of Rivalry
The intensity of rivalry for IVF Hartmann Holding AG is high, as the market is highly competitive and there are many established players.
Capital Structure
| Value | |
|---|---|
| Debt Weight | 0.88% |
| Debt Cost | 3.95% |
| Equity Weight | 99.12% |
| Equity Cost | 6.35% |
| WACC | 6.33% |
| Leverage | 0.89% |
IVF Hartmann Holding AG : Quality Control
IVF Hartmann Holding AG passed 6 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
| Company | Rational |
|---|---|
| TDVOX.ST | Tobii Dynavox AB (Publ) develops and sells assistive technology products for communication in Sweden and internationally. The company provides technology and solutions for augmentative and alternative communication for people with … |
| TSTL.L | Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and … |
| SKAN.SW | SKAN Group AG provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Asia, Europe, the Americas, and internationally. It operates in two segments: Equipment and Solutions … |
| BIOT.ST | Biotage AB (publ) provides separation technologies in the areas of organic and analytical chemistry, biomolecules, and industrial scale up applications. The company offers organic and peptide synthesis solutions; flash chromotherapy, … |
| SYNSAM.ST | Synsam AB (publ), through its subsidiaries, operates as an optical retailer in the Nordic Region. The company offers glasses, sunglasses, sports glasses, and contact lenses, as well as glasses and … |
Peers Metrics
DCF BETA
Expected Cash-Flows
Scoring Insights
Peers Group Analysis
🥇
IVF Hartmann Holding
A-Score
1-Year Total Return ->
🥈
Synsam
A-Score
1-Year Total Return ->
🥉
SKAN
A-Score
1-Year Total Return ->
4
Biotage
A-Score
1-Year Total Return ->
5
Tristel
A-Score
1-Year Total Return ->
6
